Kaiser to open medical school in 2019

Kaiser Permanente plans to open the Kaiser Permanente School of Medicine in the fall of 2019.

The school extends the innovation of the Kaiser Permanente approach to patient health and care, by redesigning physician education around strategic pillars that include providing high-quality care beyond traditional medical settings, acknowledging the central importance of collaboration and teamwork to inform treatment decisions, and addressing disparities in health, according to a release.

“Opening a medical school and influencing physician education is based on our belief that the new models of care mean we must reimagine how physicians are trained,” said Bernard J. Tyson, chairman and CEO, Kaiser Foundation Health Plan and Kaiser Foundation Hospitals. “Training a new generation of physicians to deliver on the promise of health and healthcare demonstrates our belief that our model of care is best for the current and future diverse populations in this country.”

“When fully realized, the school will enhance the healthcare provided nationwide and beyond as the newly graduated physicians bring to bear their training and knowledge wherever they choose to practice,” said Edward M. Ellison, MD, a national Permanente leader, an executive sponsor for the School of Medicine, and executive medical director, Southern California Permanente Medical Group. “Kaiser Permanente has been a catalyst for change in care delivery, and we will be a catalyst in medical education, through the opening of the Kaiser Permanente School of Medicine.”

The creation of the school also advances work the organization already does in physician education—with more than 600 new physicians currently completing their residency programs at Kaiser Permanente, and several thousand more from 50 affiliated programs who complete a portion of their training at Kaiser Permanente each year.

In the coming months, the organization will move to establish the legal entity and organizational structure for the new medical school and begin the accreditation planning and process. The school is scheduled to open in the fall of 2019 and will be located in Southern California.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.